Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Topotecan in Treating Patients With Recurrent Brain Tumors

This study has been completed.
Sponsor:
Information provided by:
Canadian Cancer Trials Group
ClinicalTrials.gov Identifier:
NCT00003372
First received: November 1, 1999
Last updated: November 7, 2010
Last verified: November 2010